Bliss GVS Pharma - Quaterly Results

01 Nov 2023 Evaluate
The revenue zoomed 23.38% to Rs. 1713.15 millions for the quarter ended September 2023 as compared to Rs. 1388.49 millions during the corresponding quarter last year.A good growth in profit of 33.18% reported to Rs. 338.91  millions over Rs. 254.47 millions of corresponding previous quarter.Operating profit for the quarter ended September 2023 rose to 529.22 millions as compared to 408.66 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 1713.15 1388.49 23.38 2803.07 2861.29 -2.03 5983.40 6363.57 -5.97
Other Income 106.14 142.31 -25.42 171.41 328.65 -47.84 507.66 326.28 55.59
PBIDT 529.22 408.66 29.50 705.00 786.47 -10.36 1409.21 1418.26 -0.64
Interest 11.78 18.39 -35.94 24.87 38.81 -35.92 100.57 43.24 132.59
PBDT 517.44 390.27 32.59 680.13 747.66 -9.03 1308.64 1402.47 -6.69
Depreciation 56.78 37.35 52.02 110.42 74.09 49.03 151.73 138.47 9.58
PBT 460.66 352.92 30.53 569.71 673.57 -15.42 1156.91 1264.00 -8.47
TAX 121.75 98.45 23.67 155.84 172.66 -9.74 302.14 337.36 -10.44
Deferred Tax 1.29 7.55 -82.91 8.29 -4.70 -276.38 -42.10 7.68 -648.18
PAT 338.91 254.47 33.18 413.87 500.91 -17.38 854.77 926.64 -7.76
Equity 104.40 103.89 0.49 104.40 103.89 0.49 104.15 103.68 0.45
PBIDTM(%) 30.89 29.43 4.96 25.15 27.49 -8.50 23.55 22.29 5.68

Bliss GVS Pharma Share Price

166.60 -9.20 (-5.23%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×